Cargando…
Regional disparities in interferon therapy for chronic hepatitis C in Japan: a nationwide retrospective cohort study
BACKGROUND: Many patients with chronic hepatitis C have been treated with interferon (IFN) therapy in Japan, especially after the introduction of subsidies for medical expenses in 2008. However, its performance and outcome have never been evaluated. Therefore, a nationwide, mail-based, retrospective...
Autores principales: | Masaki, Naohiko, Yamagiwa, Yoko, Shimbo, Takuro, Murata, Kazumoto, Korenaga, Masaaki, Kanto, Tatsuya, Mizokami, Masashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4474553/ https://www.ncbi.nlm.nih.gov/pubmed/26088426 http://dx.doi.org/10.1186/s12889-015-1891-2 |
Ejemplares similares
-
Nationwide survey on activities of regional core centers for the management of liver disease in Japan: Cumulative analyses by the Hepatitis Information Center 2009–2017
por: Setoyama, Hiroko, et al.
Publicado: (2019) -
Ex vivo induction of IFN-λ3 by a TLR7 agonist determines response to Peg-IFN/Ribavirin therapy in chronic hepatitis C patients
por: Murata, Kazumoto, et al.
Publicado: (2013) -
Comparison of peginterferon alfa-2a and alfa-2b for treatment of patients with chronic hepatitis C: a retrospective study using the Japanese Interferon Database
por: Sato, Izumi, et al.
Publicado: (2014) -
Enterococcus casseliflavus KB1733 Isolated from a Traditional Japanese Pickle Induces Interferon-Lambda Production in Human Intestinal Epithelial Cells
por: Satomi, Shohei, et al.
Publicado: (2022) -
Development of performance indicators for hepatitis countermeasures as a tool for the assessment and promotion of liver cancer prevention in Japan
por: Shimakami, Tetsuro, et al.
Publicado: (2023)